Actionable news
0
All posts from Actionable news
Actionable news in BRKS: Brooks Automation, Inc.,

Why One Analyst Is Growing Very Bullish on Life Sciences

Over the past five, 10 and 20 years, the life sciences and bioproduction segments have tended to outperform the S&P 500 more often than not. Considering the exposure to biopharma and academic end-markets that provide counter-cyclical growth to more volatile industrial end-markets, one key analyst believes that the life sciences segment is well-positioned to continue outperforming the S&P 500. As a result, the firm listed a few of its top picks within the sector.

In its Spring LabBook report, Janney Capital released data supporting its estimate that industry growth will accelerate from 3.2% last year to 4.7% this year. The firm is particularly bullish on the outlook for Asian growth, continued signs of a recovery in industrial end-markets and bioproduction. While bioproduction represents the fastest growing group in life sciences, Janney views industrial/applied markets as the key...


More